Verified Insights
Precision-driven research you can trust. We uphold rigorous data validation processes to ensure every report is reliable and based on credible sources.
+91 9425150513 (Asia) support@24lifesciences.com
+91 9425150513 (Asia) support@24lifesciences.com
Download Sample Pdf
MARKET INSIGHTS
The global pressure ulcer treatment products market size was valued at USD 2.11 billion in 2024. The market is projected to grow from USD 2.22 billion in 2025 to USD 2.99 billion by 2031, exhibiting a CAGR of 5.2% during the forecast period.
Pressure ulcer treatment products are specialized medical devices and supports designed to prevent and manage pressure ulcers, which are localized injuries to the skin and underlying tissue, typically over a bony prominence, as a result of prolonged pressure. These products function by redistributing pressure, managing moisture, and improving circulation. Core product categories include specialized support surfaces such as low-air-loss and alternating pressure mattresses and overlays, along with static air, foam, and gel cushions and positioning devices.
The market growth is primarily driven by the rising global geriatric population, who are at a higher risk for developing these wounds, and the increasing incidence of chronic conditions like diabetes and spinal cord injuries that limit mobility. Furthermore, heightened awareness about wound care and stringent healthcare regulations aimed at reducing hospital-acquired conditions are significant contributors. The market exhibits a consolidated nature, with the top four manufacturers, including Getinge and Hill-Rom, holding a combined market share exceeding 50%. Europe currently dominates as the largest regional market, accounting for nearly 40% of the global share, due to its advanced healthcare infrastructure and aging demographic profile.
Rising Geriatric and Immobile Patient Population
The increasing global geriatric population, which is highly susceptible to developing pressure injuries due to reduced mobility and skin fragility, is a primary driver. Chronic conditions such as diabetes and cardiovascular diseases further elevate risk. Healthcare systems globally are facing a growing burden, necessitating effective preventative and treatment solutions to manage patient care and reduce associated costs.
Heightened Focus on Patient Safety and Quality Care
There is a strong institutional push to reduce the incidence of hospital-acquired pressure ulcers (HAPUs), which are considered preventable adverse events. Regulatory bodies and payers are increasingly linking reimbursement to quality metrics, including pressure ulcer rates. This has driven healthcare facilities to invest in advanced support surfaces, dressings, and protocols, fueling market growth.
Technological advancements are pivotal, with smart surfaces and sensor-based monitoring systems offering proactive care.
Innovation in material science has led to the development of advanced foam dressings, silicone-based adhesives, and negative pressure wound therapy systems specifically designed for pressure ulcers. These products offer improved healing times, enhanced patient comfort, and greater ease of use for clinicians, encouraging adoption.
MARKET CHALLENGES
High Cost of Advanced Treatment Modalities
The significant upfront cost associated with advanced dynamic air mattresses, negative pressure wound therapy systems, and bioactive dressings presents a major challenge, particularly in cost-containment-focused healthcare environments and in developing regions with limited healthcare budgets. This can restrict widespread adoption, favoring cheaper, less effective alternatives.
Other Challenges
Implementation and Adherence to Protocols
Despite the availability of clinical guidelines, consistent implementation of pressure ulcer prevention and treatment protocols remains difficult. Challenges include staff training, workload, and ensuring proper patient repositioning and skin assessment, which can lead to variable patient outcomes and undermine the effectiveness of advanced products.
Reimbursement Hurdles
Reimbursement policies for pressure ulcer care products can be complex and vary significantly by region and payer. Securing adequate reimbursement for newer, more expensive technologies is often a lengthy and uncertain process, which can deter investment and slow market penetration.
Price Sensitivity and Budget Constraints
Healthcare providers, especially in public systems and long-term care facilities, operate under stringent budget constraints. The price sensitivity often leads to a preference for low-cost, basic products over premium solutions, even when clinical evidence supports the latter's superior efficacy, thereby restraining the growth of the advanced product segment.
Prevention-First Initiatives Reducing Treatment Demand
Successful, large-scale pressure ulcer prevention programs are demonstrating significant results in reducing the incidence of new ulcers. While positive for patient outcomes, the success of these initiatives can paradoxically temper the growth of the treatment market by shrinking the patient pool requiring advanced therapeutic interventions.
Expansion into Home Care Settings
The shift towards home-based care and the growing preference for aging in place create a substantial opportunity. There is increasing demand for user-friendly, portable, and effective pressure ulcer management products designed for the home environment, including low-air-loss overlays and easy-to-apply advanced dressings.
Integration of Digital Health and Telemedicine
The convergence of medical devices with digital health platforms offers significant potential. Smart support surfaces with integrated pressure mapping and sensors can transmit data to healthcare providers for remote monitoring, enabling early intervention and personalized care plans. This integration supports value-based care models and opens new revenue streams.
Emerging Markets with Improving Healthcare Infrastructure
Rapidly developing economies are investing heavily in healthcare infrastructure and are witnessing a rise in disposable income and health awareness. This presents a largely untapped market for both basic and advanced pressure ulcer care products, offering lucrative growth opportunities for market players willing to navigate these regions.
Segment Analysis:| Segment Category | Sub-Segments | Key Insights |
| By Type |
|
Mattresses represent the leading product segment, driven by their fundamental role in pressure redistribution and prevention across various care settings. These products offer significant clinical advantages by continuously adjusting support to alleviate pressure points on high-risk anatomical areas. The segment benefits from ongoing technological advancements, including alternating pressure and low-air-loss technologies, which enhance patient comfort and improve treatment outcomes. Furthermore, mattresses are considered a cornerstone of pressure ulcer management protocols in both acute and long-term care environments, establishing a consistently high demand. |
| By Application |
|
Hospital is the dominant application segment for pressure ulcer treatment products, primarily due to the high concentration of critically ill and immobile patients requiring advanced care. Hospitals maintain rigorous standards for patient safety and infection control, mandating the use of sophisticated support surfaces. The segment is characterized by a strong focus on evidence-based practices, where specialized beds and mattresses are integral to preventing hospital-acquired pressure injuries, a key quality metric. Investments in this segment are driven by the need to reduce patient complications, shorten hospital stays, and manage associated healthcare costs effectively. |
| By End User |
|
Geriatric Care Facilities constitute the leading end-user segment, reflecting the strong correlation between advanced age, reduced mobility, and susceptibility to pressure ulcers. These facilities require durable, easy-to-use products that can be integrated into long-term daily care routines. The demand is further amplified by the growing global geriatric population, which increases the patient base needing continuous pressure management. Products in this segment are valued for their reliability, ease of maintenance, and ability to improve the quality of life for residents, making geriatric care a cornerstone of sustained market demand. |
| By Product Technology |
|
Alternating Pressure technology is the leading segment, prized for its dynamic mechanism that systematically shifts pressure points to enhance blood circulation and prevent tissue breakdown. This technology is particularly effective for high-risk patients who are largely immobile, as it provides active prevention and treatment. The segment's growth is propelled by clinical endorsements and its proven efficacy in reducing the incidence of pressure injuries in intensive care and long-term settings. Continuous innovation to improve comfort and interface pressure management solidifies its dominant position. |
| By Care Setting |
|
Long-Term Care is the predominant care setting, characterized by the extended duration of patient stays which significantly heightens the risk of developing pressure ulcers. This setting demands robust, cost-effective solutions that provide continuous protection over months or years. The focus is on products that combine therapeutic effectiveness with durability and ease of use for caregivers. The segment's importance is growing due to demographic shifts towards older populations and an increased emphasis on aging in place, which expands the need for reliable pressure management solutions outside of acute hospitals. |
A Consolidated Market Led by Established Medical Equipment Giants
The global pressure ulcer treatment products market is characterized by a high degree of consolidation, with the top four manufacturers accounting for over 50% of the total market share. Leading this group are multinational medical technology companies such as Getinge, Hill-Rom, and Stryker, which leverage their extensive distribution networks, strong brand recognition, and diverse portfolios of patient handling and wound care solutions. These dominant players primarily focus on advanced therapeutic support surfaces, including low-air-loss beds, alternating pressure mattresses, and specialized cushions, which are widely used in hospital and long-term care settings. Their competitive strategies are heavily reliant on continuous product innovation, strategic acquisitions to broaden their market reach, and providing integrated clinical solutions to healthcare providers.
Beyond the market leaders, a significant number of specialized and regional players compete effectively by focusing on niche segments and cost-competitive offerings. Companies like Recticel, EHOB, and Permobli have carved out strong positions by specializing in high-quality foam-based mattresses and static pressure redistribution cushions. These players often target specific applications such as home care or nursing homes, where value-for-money and ease of use are critical purchasing factors. Furthermore, manufacturers like Linet Spol and Stiegelmeyer are prominent in the European market, offering a range of hospital beds and support surfaces that comply with regional standards and reimbursement policies. The competitive dynamics are further influenced by manufacturers supplying products for private-label brands and distributors, adding another layer to the market's structure.
List of Key Pressure Ulcer Treatment Products Companies ProfiledGetinge
Recticel
Linet Spol. s.r.o.
Stiegelmeyer GmbH & Co. KG
Permobli GmbH
GF Health Products, Inc.
ArjoHuntleigh (a part of Getinge)
Paramount Bed Holdings Co., Ltd.
Medline Industries, LP
Joerns Healthcare LLC
Talley Group Ltd.
The global Pressure Ulcer Treatment Products market demonstrates a clear trajectory of steady expansion, valued at $2112 million in 2024 and projected to reach $2986 million by 2031, representing a compound annual growth rate (CAGR) of 5.2%. This sustained growth is primarily driven by the increasing global geriatric population, which is highly susceptible to pressure ulcers due to reduced mobility and thinner skin. As life expectancy rises worldwide, the demand for preventive and therapeutic solutions is expected to intensify, creating a robust and predictable market environment. The high prevalence of pressure ulcers in long-term care settings ensures a consistent need for specialized products.
Other TrendsMarket Consolidation and Competitive Landscape
The market is characterized by a consolidated competitive landscape, with the top four manufacturers including Getinge, Recticel, Linet Spol, and Invacare collectively holding a market share exceeding 50%. This concentration indicates mature competition where established players leverage strong distribution networks and brand recognition. Key strategies among these leaders include continuous product innovation, particularly in smart technologies for pressure redistribution, and strategic mergers and acquisitions to expand their product portfolios and geographic footprint. This dynamic fosters a focus on high-quality, technologically advanced solutions.
Dominance of Mattresses and Hospital ApplicationsAnalysis by product type reveals distinct segmentation, with mattresses representing the most significant product category. These products are essential for pressure redistribution and are a standard of care in institutional settings. In terms of application, the hospital segment currently holds the largest market share. This is due to the high concentration of high-risk, immobilized patients requiring acute care and sophisticated pressure ulcer management protocols. However, the growing trend of home healthcare is expected to accelerate the growth of the home use segment, as patients and providers seek cost-effective and comfortable solutions for long-term care outside clinical environments.
Europe Leads, but Asia-Pacific Emerges as a Key Growth RegionGeographically, Europe represents the largest market for pressure ulcer treatment products, accounting for nearly 40% of the global share. This leadership is attributed to well-established healthcare infrastructure, high awareness levels, and favorable reimbursement policies. North America follows as another major market. Looking forward, the Asia-Pacific region is projected to exhibit the highest growth rate during the forecast period. This is fueled by increasing healthcare expenditure, a rapidly aging population in countries like Japan and China, and the ongoing development and modernization of healthcare facilities across the region.
Regional Analysis: Pressure Ulcer Treatment Products MarketEurope
Europe represents a highly significant market for pressure ulcer treatment products, characterized by well-established public healthcare systems, stringent regulatory standards via the MDR, and a growing elderly demographic. Countries like Germany, the UK, and France are at the forefront, with national health services providing strong guidance on wound care protocols, which standardizes product usage. The market is driven by a high emphasis on cost-effective care and evidence-based practices, leading to widespread adoption of advanced dressings and pressure redistribution support surfaces. The presence of a large network of nursing homes and long-term care facilities creates substantial demand for both preventive and therapeutic products. While reimbursement systems vary by country, there is a general trend towards funding advanced therapies that demonstrate clear clinical benefits and cost savings, supporting market growth.
Asia-Pacific
The Asia-Pacific region is the fastest-growing market for pressure ulcer treatment products, fueled by rapidly improving healthcare infrastructure, increasing healthcare expenditure, and a rising awareness of advanced wound care. Large populations in countries like China, India, and Japan, coupled with increasing life expectancy and a growing prevalence of chronic diseases, are expanding the patient base significantly. The market is characterized by a mix of low-cost basic products and a growing adoption of advanced technologies, particularly in urban hospitals and private healthcare centers. Local manufacturing is increasing, making products more accessible, while government initiatives to improve hospital standards are boosting demand. However, market penetration varies widely, with advanced economies like Japan and Australia showing sophistication similar to Western markets, while emerging economies are still developing their wound care ecosystems.
South America
The South American market for pressure ulcer treatment products is evolving, with growth driven by economic development, expanding private healthcare sectors, and gradual improvements in public health awareness. Brazil and Argentina are the key markets, where urban hospitals are increasingly adopting international wound care guidelines and incorporating advanced dressings and support surfaces into their formularies. The market faces challenges related to economic volatility and disparities in healthcare access between urban and rural areas, which can limit the uniform adoption of advanced products. Demand is primarily concentrated in major private hospitals and clinics, with a growing recognition of the importance of pressure ulcer prevention in improving patient outcomes and reducing hospital stays. The region shows potential for growth as healthcare investments continue and training for healthcare professionals expands.
Middle East & AfricaMiddle East & Africa
The Middle East and Africa region presents a diverse and developing market for pressure ulcer treatment products. The affluent Gulf Cooperation Council (GCC) countries, such as the UAE and Saudi Arabia, are leading the adoption of advanced medical technologies, driven by high healthcare spending, state-of-the-art hospital infrastructure, and a focus on medical tourism. These markets show strong demand for sophisticated wound care solutions. In contrast, much of Africa faces significant challenges, including limited healthcare infrastructure, budget constraints, and lower awareness, leading to a reliance on basic wound care products. Nonetheless, increasing government and international organization focus on improving hospital-acquired infection and injury prevention is creating gradual growth opportunities, particularly for cost-effective advanced dressings and basic pressure relief devices in urban medical centers.
This market research report offers a holistic overview of global and regional markets for the forecast period 20252032. It presents accurate and actionable insights based on a blend of primary and secondary research.
Market Overview
Global and regional market size (historical & forecast)
Growth trends and value/volume projections
Segmentation Analysis
By product type or category
By application or usage area
By end-user industry
By distribution channel (if applicable)
Regional Insights
North America, Europe, Asia-Pacific, Latin America, Middle East & Africa
Country-level data for key markets
Competitive Landscape
Company profiles and market share analysis
Key strategies: M&A, partnerships, expansions
Product portfolio and pricing strategies
Technology & Innovation
Emerging technologies and R&D trends
Automation, digitalization, sustainability initiatives
Impact of AI, IoT, or other disruptors (where applicable)
Market Dynamics
Key drivers supporting market growth
Restraints and potential risk factors
Supply chain trends and challenges
Opportunities & Recommendations
High-growth segments
Investment hotspots
Strategic suggestions for stakeholders
Stakeholder Insights
This report is designed to support strategic decision-making for a wide range of stakeholders, including:
Pharmaceutical and biotech companies
Medical device and diagnostics manufacturers
Healthcare providers and hospital systems
Contract research and manufacturing organizations
Investors, consultants, and policy makers
-> Global pressure ulcer treatment products market was valued at USD 2.11 billion in 2024 and is expected to reach USD 2.99 billion by 2031.
Which key companies operate in Global Pressure Ulcer Treatment Products Market?
-> Key players include Getinge, Recticel, Linet Spol, Invacare, and Hill-Rom, among others.
-> The market is projected to grow at a CAGR of 5.2% during the forecast period.
-> Europe is the largest regional market, accounting for nearly 40% of the global share.
-> Core product categories include beds, mattresses, and cushions designed to redistribute pressure and improve circulation.
“The data provided by 24LifeScience was clear, well-organized, and useful for internal strategy planning. It helped us understand the competitive landscape more effectively.”
“We used one of their market overview reports for early-stage feasibility work. It gave us a helpful snapshot of current trends and key players in our therapeutic area.”
“I appreciated the team’s responsiveness and willingness to adjust the scope based on our feedback. The final report was aligned with our expectations and timelines.”
“Their custom report on clinical trial trends was a helpful reference as we explored new indications."
“As someone working on early product planning, I found their therapeutic area briefs quite useful. The information was presented in a way that made it easy to extract key takeaways.”
“We didn’t need anything overly complex—just solid, dependable data. 24LifeScience delivered exactly that, without unnecessary fluff.”
“Their reports gave us a good foundation to start our own market assessment. While we supplemented it with other data, this was a great starting point.”
“I’ve used a few of their reports for academic and grant writing purposes. They’re generally well-cited and reliable for understanding market scope.”
At 24LifeScience, we combine domain expertise with dependable research delivery. What truly differentiates us isn't just what we do — it's how we do it. Our clients trust us because we offer consistency, security, value, and most importantly, insight that drives action.
Precision-driven research you can trust. We uphold rigorous data validation processes to ensure every report is reliable and based on credible sources.
We uphold rigorous data validation processes to ensure every report is reliable, up-to-date, and based on credible sources.
24LifeScience powers research for top firms in 20+ nations.Chosen by leading life sciences companies worldwide.
We offer competitive pricing models that align with your project scope — no hidden charges, no lock-in. Tailored pricing for every scale and need.
8–10+ years of life sciences expertise turned into strategic insights.We don’t just summarize data we contextualize it.
Whether it's a ready-made report or a custom project, we deliver within the promised timeline With real-time updates